Cardiovascular Needle Market Share, Size, Analysis 2028

report image

Cardiovascular Needle Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Round-Bodied Needles and Cutting Needles), Application (Open Heart Surgery and Cardiac Valve Procedures), Usage (Single Use and Multiple Uses), and End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Cardiovascular Centers) Geography

Publication Month: Sep 2021 | Report Code: TIPRE00004729 | No. of Pages: 171 | Category: Medical Device | Status: Published

The cardiovascular needle market was valued at US$ 84.429 million in 2021 and is projected to reach US$ 137.855 million by 2028; it is expected to grow at a CAGR of 7.3 % from 2021 to 2028.  

The cardiovascular needles are used during open-heart surgeries, cardiac valve procedures, heart transplantation procedures, coronary artery bypass graft surgeries, and so on. These needles are of two types: single use or eyeless needles and multiple use or eyed needles. Cardiovascular needles are manufactured from new stainless-steel alloys constituting high concentrations of nickel, Surgalloy, and Ethalloy.    

The cardiovascular needle market has been segmented on the basis of type, application, usage, end user, and geography. The market, by geography, is primarily segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the cardiovascular needle market, emphasizing on parameters such as market trends, technological advancements, and market dynamics along with competitive landscape analysis of the globally leading market players.  

Lucrative Regions for Cardiovascular Needle Market

Lucrative Regions for Cardiovascular Needle Market

Get more information on this report :

Market Insights
Increasing Prevalence of Cardiovascular Diseases Boosts Cardiovascular Needle Market Growth

Cardiovascular diseases (CVDs) are the disorders of heart and blood vessels, and the category includes cerebrovascular disease, coronary heart disease, rheumatic heart disease, and other conditions. Tobacco consumption, unhealthy diet, and physical inactivity, which increase the risk of heart attacks and strokes, are a few of the major lifestyle factors that lead to the CVDs. Other risk factors causing these diseases include hypertension, diabetes, and increased cholesterol levels. CVDs are among the top 10 causes of death across the world. According to the World Health Organization (WHO), cardiovascular diseases are number one cause of the death across the world. Cardiovascular diseases (CVDs) are likely to remain the largest cause of morbidity and mortality across the world. As per WHO data, ~17.9 million people in the world died from CVDs in 2016, which was 31.0% of the total mortality reported in that year. Among these, ~85% death cases were due to heart attack and stroke. Fat depositions around blood vessels that prevents blood from flowing to the heart or brain is a main cause of heart attack and stroke. Bleeding vessels or blood clots in brain are a few other causes of stroke.

According to the European Cardiovascular Disease Statistics 2017, CVDs cause 3.9 million and more than 1.8 million death cases in Europe and European Union (EU), respectively, every year. Thus, these diseases account for 45.0% and 37.0% of total mortality in Europe and the EU, respectively. Furthermore, as per the American Heart Association (AHA) 2019 statistics, 121.5 million adults in the US, i.e., ~50% of the US adult population, suffer from CVDs every year. According to the Journal of the American College of Cardiology, Asia has increasingly high prevalence of high blood pressure, diabetes, elevated cholesterol levels. Countries such as Japan, China, and India are the major contributors to the total CVD incidence in the region. Thus, the significantly rising incidence of CVDs across the world is contributing to the high demand for diagnostic and treatment cardiovascular devices, which is driving the cardiovascular needles market growth.  

Type-Based Insights

Based on type, the cardiovascular needle market is segmented into round-bodied needles and cutting needles. The round-bodied needles segment would account for a larger market share in 2021, and the cutting needles segment is anticipated to register a higher CAGR in the market during the forecast period.    

Cardiovascular Needle Market, by Type – 2021 AND 2028

Cardiovascular Needle Market, by Type – 2021 AND 2028

Get more information on this report :

Application-Based Insights 

Based on application, the cardiovascular needle market is segmented into open heart surgery and cardiac valve procedures. The open-heart surgery segment is expected to hold a larger share of the market in 2021, and it is estimated to register a higher CAGR in the market during 2021–2028. Growth of the open-heart surgery segment is attributed to the increasing open-heart surgeries across the globe.


Report Coverage

Usage–Based Insights

Based on usage, the cardiovascular needle market is segmented into single use and multiple use. The single use segment is estimated to account for a larger market share in 2021. The market for this segment is estimated to grow at a higher CAGR from 2021 to 2028.

End User–Based Insights

Based on end user, the cardiovascular needle market is segmented into hospitals and clinics, ambulatory surgical centers, and cardiovascular centers. The hospitals and clinics segment would hold the largest share of the market in 2021; it is further estimated to register the highest CAGR in the market during the forecast period.  

The COVID-19 pandemic has become the most significant challenge across the world. As this pandemic has stressed healthcare systems across the globe, prioritizing the limited resources was essential to minimize hospital admissions.  Cardiac surgical patients not only require vital ICU resources but are also potentially in the highest risk category of complications of COVID-19. Hence, most of the hospitals and surgical enters has considered to cancel or postponed elective surgeries including cardiovascular surgeries. Hence impact of COVID 19 is expected to be somewhat negative on cardiovascular needle market in short run. However, in long run, as the vaccination schedule will establishes and transmission rate decreases, healthcare systems will return to normal and will have increased demand for cardiovascular needle, which will support the market.

Acquisitions, collaborations, partnerships, product launches, and expansions are commonly adopted strategies by companies to expand their footprint worldwide and meet the growing demand. The cardiovascular needle market players have been chiefly adopting the strategy of product innovation to cater to the changing customer demand across the world, which also helps them maintain their brand name globally.

Company Profiles

  • Ethicon (Johnson & Johnson Services, Inc.)    
  • Mani, Inc     
  • Barber of Sheffield                              
  • FSSB surgical needles GmbH                  
  • Medtronic     
  • Aurolab       
  • Teleflex Incorporated                           
  • Meril Life Sciences Pvt. Ltd.                   
  • CP Medical     
  • SMB Corporation of India

Frequently Asked Questions

The cardiovascular needles are used during a number of cardiovascular surgeries such as open-heart surgery, cardiac valve procedures, heart transplant, coronary artery bypass graft surgery, and many more surgeries need surgical needles. These cardiovascular needles are of two types: single use or eyeless needles and multiple use or eyed needles. Cardiovascular needles are manufactured from new stainless-steel alloys containing high concentrations of nickel, Surgalloy and Ethalloy.
The factors that are driving growth of the market are increase in prevalence of cardiovascular diseases across the world and rising geriatric population. There are also other factors that fuel the growth of the market such as excessive intake of tobacco, high number of smoking population, obesity, increasing co-morbidities, and changing standard of living.
The factors that are restraining the adoption of cardiovascular needle are increasing use of surgical staples instead of needles and suture.
The Cardiovascular Needle market majorly consists of the players such as players Ethicon (Johnson & Johnson Services, Inc.), MANI, INC., Barber of Sheffield, FSSB surgical needles GmbH, Medtronic, Aurolab., Teleflex Incorporated., Meril Life Sciences Pvt. Ltd., CP Medical., SMB Corporation of India and among others.

The List of Companies - Cardiovascular Needle Market

  1. Ethicon (Johnson & Johnson Services, Inc.)          
  2. MANI, INC            
  3. Barber of Sheffield           
  4. FSSB surgical needles GmbH       
  5. Medtronic            
  6. Aurolab    
  7. Teleflex Incorporated        
  8. Meril Life Sciences Pvt. Ltd.         
  9. CP Medical          
  10. SMB Corporation of India
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Cardiovascular Needle market.
  • Highlights key business priorities in order to assist companies to realign their business strategies. 
  • The key findings and recommendations highlight crucial progressive industry trends in the global Cardiovascular Needle market, thereby allowing players across the value chain to develop effective long-term strategies. 
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. 
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it. 
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00004729
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




christmas_festive_offer

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000 $2700
  • $4550 $4095
  • $6550 $5568
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount